MNV-201 is also being studied in a Phase Ib for low-risk Myelodysplastic Syndrome; Preliminary clinical data demonstrate safety and efficacy HAIFA, Israel, (GLOBE NEWSWIRE) -- Minovia Therapeutics ...

Rescue workers saved a 63-year-old woman from the rubble of a building in Myanmar’s capital on Tuesday, but hope was fading ...

Washington’s 26% tariff move threatens to disrupt India’s medtech exports, adding pressure on a sector already grappling with ...

Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a "strange" ...

Levels of floating seaweed mats, known as sargassum, have skyrocketed in the Atlantic Ocean in the past month, with the total ...

The B7-33 peptide, a derivative of the H2-relaxin hormone, has garnered attention in scientific research due to its potential ...

Today the United States announced new tariffs on products manufactured outside the US, including a 10% tariff on products manufactured in New Zealand.

At a month old, she received a catheterized balloon procedure to place a balloon inside her aortic valve to open it so blood ...

Muscatine High School student Jack Harfst gets ready to go for a ride on the Seat Belt Convincer during the 11th annual Bayer ...